Clinical Trial Update: A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery. [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated whether epoetin alfa reduces the need for blood transfusions around major orthopedic surgery; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Blood Transfusion | Phase 3 | Status: COMPLETED